Satellite Banner
Technology Networks Header
Friday, November 28, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Era7 Launches its New Service Genome7
Wednesday, October 15, 2014
An integrated solution for Cancer Genomics.

DNASTAR Releases Lasergene 12.1 Software
Saturday, October 11, 2014
Lasergene 12.1 integrates cloud capability with ground computers.

Bio-Rad Introduces Real-Time PCR Assays for Rat Genome
Thursday, October 09, 2014
Wet-lab validated PrimePCR™ Rat Genome Assays ensure accurate quantitative PCR results.

3D Triculture Model for Evaluating Breast Cancer Progression
Wednesday, October 01, 2014
New application note introduces a more predictive and realistic model for drug screening of cancer therapeutics.

A New Solid-State Platform for High-Throughput ChIP
Thursday, September 25, 2014
Porvair’s new technical article provides an introduction to Chromatrap® 96.

Easy and Cost-Effective Generation of siRNAs from Full-Length Target Genes
Wednesday, September 24, 2014
Dicer siRNA generation kit from AMSBIO.

RAININ's New LR Low Retention Pipette Tips
Tuesday, September 23, 2014
New tips will improve users pipetting accuracy.

Fluidigm’s New Juno™ System Shatters Barriers for SNP Genotyping
Friday, September 19, 2014
New system provides simple workflow, requires minimal amount of sample input and hands-on time.

Tecan Offers NGS Sample Preparation at the Touch of a Button
Friday, September 19, 2014
Tecan’s Freedom EVO NGS workstation to offer robust and reliable automation.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 2545
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv